LeadIQ logo
Learn more at LeadIQ.com

Insights

Early Detection Leader Target healthcare providers and payers with AI-powered, lab-based early detection tests (OneTest for Cancer, OneTest for Longevity) to expand preventive care offerings and reduce long-term treatment costs.

At-Home Testing Leverage the at-home needle-free collection model to partner with direct-to-consumer platforms, wellness programs, and employer health initiatives seeking convenient, scalable diagnostic solutions.

Clinical Validation Position the CAP-accredited and CLIA-licensed lab as a differentiator to win inquiries from clinics and research institutions requiring robust quality standards and real-world data integration.

Growth Financing With a modest funding base and early revenue, pursue partnerships with venture-backed diagnostics firms or strategic investors to scale assay development, data infrastructure, and go-to-market capabilities.

Data and AI Advantage Highlight explainable AI and access to real-world data to collaborate with healthcare IT vendors, EMR/AIS vendors, and health analytics platforms seeking interoperable, transparent decision-support tools.

20/20 Biolabs, Inc. Tech Stack

20/20 Biolabs, Inc. uses 8 technology products and services including html5media, CompTIA A+, MySQL, and more. Explore 20/20 Biolabs, Inc.'s tech stack below.

  • html5media
    Audio, Video, Graphics
  • CompTIA A+
    Certificates
  • MySQL
    Database
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Priority Hints
    Performance
  • Google Tag Manager
    Tag Management
  • Apache HTTP Server
    Web Servers

20/20 Biolabs, Inc.'s Email Address Formats

20/20 Biolabs, Inc. uses at least 2 format(s):
20/20 Biolabs, Inc. Email FormatsExamplePercentage
FLast@2020gene.comJDoe@2020gene.com
82%
FirstL@2020gene.comJohnD@2020gene.com
10%
Last@2020gene.comDoe@2020gene.com
8%
FLast@2020biolabs.comJDoe@2020biolabs.com
100%

Frequently Asked Questions

What is 20/20 Biolabs, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact 20/20 Biolabs, Inc.'s main corporate office by phone at
+1-240-453-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is 20/20 Biolabs, Inc.'s official website and social media links?

Minus sign iconPlus sign icon20/20 Biolabs, Inc.'s official website is 2020biolabs.com and has social profiles on LinkedInCrunchbase.

What is 20/20 Biolabs, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon20/20 Biolabs, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 20/20 Biolabs, Inc. have currently?

Minus sign iconPlus sign iconAs of July 2026, 20/20 Biolabs, Inc. has approximately 28 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chairman: J. C.Senior Vice President And Chief Operating Officer: V. K.Sales Manager: D. L.. Explore 20/20 Biolabs, Inc.'s employee directory with LeadIQ.

What industry does 20/20 Biolabs, Inc. belong to?

Minus sign iconPlus sign icon20/20 Biolabs, Inc. operates in the Biotechnology Research industry.

What technology does 20/20 Biolabs, Inc. use?

Minus sign iconPlus sign icon20/20 Biolabs, Inc.'s tech stack includes html5mediaCompTIA A+MySQLjQueryjQuery MigratePriority HintsGoogle Tag ManagerApache HTTP Server.

What is 20/20 Biolabs, Inc.'s email format?

Minus sign iconPlus sign icon20/20 Biolabs, Inc.'s email format typically follows the pattern of FLast@2020gene.com. Find more 20/20 Biolabs, Inc. email formats with LeadIQ.

How much funding has 20/20 Biolabs, Inc. raised to date?

Minus sign iconPlus sign icon As of July 2026, 20/20 Biolabs, Inc. has raised $1.4M in funding. The last funding round occurred on Jun 16, 2020 for $1.4M.

When was 20/20 Biolabs, Inc. founded?

Minus sign iconPlus sign icon20/20 Biolabs, Inc. was founded in 2000.

20/20 Biolabs, Inc.

Biotechnology ResearchMaryland, United States11-50 Employees

20/20 BioLabs, Inc. operates a CAP-accredited and CLIA-licensed laboratory in Gaithersburg, Maryland, conducting AI-powered, laboratory-based blood tests focused on the early detection and prevention of cancers and chronic diseases. Through its OneTest brand, including OneTest for Cancer and OneTest for Longevity, the company offers tests designed to deliver affordable, accurate, and actionable health insights derived from machine learning and real-world data. These tests enable individuals to track biological age, monitor systemic inflammation, and follow evidence-based dietary and lifestyle guidance to lower disease risk, with at-home, needle-free sample collection and explainable AI supporting the results.

Section iconCompany Overview

Phone number
+1-240-453-****
Website
2020biolabs.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1.4M

    20/20 Biolabs, Inc. has raised a total of $1.4M of funding over 7 rounds. Their latest funding round was raised on Jun 16, 2020 in the amount of $1.4M.

  • $1M$10M

    20/20 Biolabs, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1.4M

    20/20 Biolabs, Inc. has raised a total of $1.4M of funding over 7 rounds. Their latest funding round was raised on Jun 16, 2020 in the amount of $1.4M.

  • $1M$10M

    20/20 Biolabs, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. C.
    Chairman
    Phone icon
    Mobile Phone
  • Stylized image of a person
    V. K.
    Senior Vice President And Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. L.
    Sales Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. C.
    Acting General Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. C.
    Office Manager
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    M. R.
    Representative Of The Company 20/20 Genesystems In Israel, Russia, Ukraine
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. P.
    General Supervisor
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.